JP Morgan Chase’s ChemoCentryx, Inc. CCXI Stock Holding History

JP Morgan Chase’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-256,800	Closed	-$6.36M	–	7119
2022 Q2	$6.36M	Buy	+256,800	New	+$5.66M	﹤0.01%	2563
2021 Q4	–	Sell	-22,500	Closed	-$385K	–	7189
2021 Q3	$385K	Buy	+22,500	New	+$351K	﹤0.01%	4875
2020 Q4	–	Sell	-45,700	Closed	-$2.45M	–	6065
2020 Q3	$2.45M	Buy	+45,700	New	+$2.46M	﹤0.01%	3108

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

JP Morgan Chase's CCXI Position: Q4 2022 in Review

JP Morgan Chase sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 211,078 shares — an estimated $10.9M sold.

JP Morgan Chase first reported a position in CCXI in Q2 2013 and held it in 34 quarters. The position peaked at $10.9M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

JP Morgan Chase reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
JP Morgan Chase sold 211,078 ChemoCentryx, Inc. shares in Q4 2022, an estimated $10.9M.
JP Morgan Chase first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 34 quarters.
JP Morgan Chase's ChemoCentryx, Inc. position peaked at $10.9M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.